Whatever the stage of clinical development, we recognise that statistical input is critical to the success of any study. We can support you in:
Engaging with a statistician at the early stages of the protocol development process will ensure that your study is appropriately designed to answer the objectives and substantiate product claims. We can assist with sections including randomisation and blinding, definition of endpoints, sample size and statistical methods.
One of the pivotal aspects of planning a clinical trial is the calculation of the sample size.
Starting with a clear definition of the primary endpoint and the treatment effect of interest, PCS then utilise historical data and relevant publications to derive an informed sample size estimate for your study.
Randomisation and blinding are fundamental in most clinical studies. PCS is able to generate and store the randomisation schedule for your study. If we are also analysing your data, an independent statistician will be assigned to this task to ensure blinding is maintained.
Expert statistical input into the protocol to ensure your study is appropriately designed to answer the objectives.
Development of a suite of SAS programs to generate report ready tables, figures and data listings.
Utilisation of historical data and relevant publications to provide sample size estimates.
Preparation of a statistical analysis plan, and usage of the most appropriate statistical methods to leverage your study data.
Preparation of randomisation schedules.
Statistical input into the clinical study report and analyses for publications.